Shep

New NHS research study - putting people on benzos long term

3 posts in this topic

This is the PDF with all of the details of this research study:

 

Benzodiazepines for treatment resistant panic disorder

 

This study will place people on long-term benzo treatment.  In order to qualify to participate in this study, you must meet these requirements:

 

"Several definitions of treatment resistance exist including patients who have not responded adequately to at least three evidence-based treatments recommended by NICE, such as two courses of antidepressants and a course of CBT."

 

So it seems the NHS is treating antidepressant withdrawal with benzos. Not only is this a crime against the people who sign up for the study, it's sending a message to doctors to keep prescribing benzos. 

 

We are going in circles. . . . 

 

I'm not feeling up to taking this on, but for anyone who is, the PDF listed some contact information. For anyone who wishes to contact them with why this is a really bad idea, here it is: 

 

Should you have any queries, please contact htacet@nihr.ac.uk or telephone 02380 595544

Share this post


Link to post
Share on other sites

Thanks for posting Shep.

 

Under timelines it says

Applicants should consider however that there is a pressing need within the NHS for this research, and so...

 

No doubt this research is pressing because the horror of ssri damage to people is now coming to light and the NHS is being flooded with the iatrogenically harmed and are desperate for it to go away....

 

[bold insert mine]

 

Clinical equipoise exists over the longer term use of benzodiazepines for treatment resistant panic disorder. Benzodiazepines have high level evidence for efficacy for panic disorder but NICE states that they should not be used due to concerns over dependence and other harmful effects - clinicians are discouraged from prescribing their long-term use. In contrast, a recent report from the Royal College of Psychiatrists Psychopharmacology Special Interest Group and the British Association of Psychopharmacology [oh no here we go....wait for it] highlights clinical circumstances, including chronic treatment-resistant anxiety disorders, in which longer-term prescription of benzodiazepines might be more reasonable than the alternatives. The report suggests that this should not necessarily be regarded as a deviation from good clinical practice. In addition, the British National Formulary states that in panic disorders resistant to antidepressant therapy, an unlicensed benzodiazepine (lorazepam or clonazepam) may be used. Clonazepam has been the subject of recent non-UK research in panic disorder and evidence suggests it may have a sustained therapeutic effect. High quality UK data is needed to definitively examine the effectiveness of a long-term course of a long-acting benzodiazepine for treatment resistant panic disorder. Several recent publications have called for a reappraisal of the role of benzodiazepines for conditions such as treatment resistant panic disorder and the proposed trial could contribute to future updates by NICE.

 

Pharma must be behind this......

This is a big disappointment so much for July 11th World benzo awareness day when we remember all those harmed by these drugs.

Share this post


Link to post
Share on other sites

 

No doubt this research is pressing because the horror of ssri damage to people is now coming to light and the NHS is being flooded with the iatrogenically harmed and are desperate for it to go away....

 

 

 

 

Thanks for your insightful comment, NZ.

 

Yes, you are quite right about the damage coming to light. The timeframe for this is interesting, as the United Nations is just now criticizing the use of drugs to treat depression:

 

United Nations Statement Criticizes Medicalization of Depression on World Health Day

 

The full statement is here:

 

http://www.ohchr.org/EN/NewsEvents/Pages/DisplayNews.aspx?NewsID=21480&LangID=E

 

And in this statement:

 

For example, there exists compelling evidence that higher prevalence of depression is strongly linked to early childhood adversities, including toxic stress and sexual, physical and emotional child abuse, as well as to inequalities and violence, including gender based inequalities and gender based violence, and many other adverse conditions which people, especially those in vulnerable situations such as poverty or social exclusion, face when their basic needs are not met and their rights are not protected.

 

Integrating this evidence and securing human rights entitlements requires a new approach that balances population-based interventions with individual care and support.

 

 

But I guess instead of ending child abuse, domestic abuse, and ending poverty, the NHS would rather we all take benzos. That's easier than admitting the enormous harm that has been caused. Yes, I also do believe Big Pharma is behind this, probably in many different ways. 

 

Quite extraordinary and bizarre times we live in.  

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!


Register a new account

Sign in

Already have an account? Sign in here.


Sign In Now